| The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes F Zorat, V Shetty, D Dutt, L Lisak, F Nascimben, K Allampallam, S Dar, ... British journal of haematology 115 (4), 881-894, 2001 | 207 | 2001 |
| Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates V Shetty, S Hussaini, LT Broady-Robinson, K Allampallam, S Mundle, ... Blood, The Journal of the American Society of Hematology 96 (4), 1388-1392, 2000 | 111 | 2000 |
| Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome K Allampallam, V Shetty, S Mundle, D Dutt, H Kravitz, PL Reddy, S Alvi, ... International journal of hematology 75, 289-297, 2002 | 110 | 2002 |
| Increased incidence of mitochondrial cytochrome c‐oxidase gene mutations in patients with myelodysplastic syndromes PL Reddy, VT Shetty, D Dutt, A York, S Dar, SD Mundle, K Allampallam, ... British journal of haematology 116 (3), 564-575, 2002 | 93 | 2002 |
| The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes K Allampallam, D Dutt, C Nair, V Shetty, S Mundle, L Lisak, C Andrews, ... Journal of hematotherapy & stem cell research 9 (2), 247-255, 2000 | 58 | 2000 |
| Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes. K Allampallam, V Shetty, S Hussaini, L Mazzoran, F Zorat, R Huang, ... Anticancer research 19 (6B), 5323-5328, 1999 | 58 | 1999 |
| Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes S Alvi, A Shaher, V Shetty, B Henderson, B Dangerfield, F Zorat, L Joshi, ... Leukemia research 25 (11), 941-954, 2001 | 40 | 2001 |
| Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis S Dar, S Mundle, T Andric, H Qawi, V Shetty, S Reza, BY Mativi, ... European journal of haematology 62 (2), 90-94, 1999 | 37 | 1999 |
| Excessive apoptosis, increased phagocytosis, nuclear inclusion bodies and cylindrical confronting cisternae in bone marrow biopsies of myelodysplastic syndrome patients V Shetty, S Hussaini, S Alvi, L Joshi, A Shaher, B Dangerfield, ... British journal of haematology 116 (4), 817-825, 2002 | 33 | 2002 |
| Presence of activation-related m-RNA for EBV and CMV in the bone marrow of patients with myelodysplastic syndromes S Mundle, K Allampallam, KA Rashid, B Dangerfield, J Cartlidge, D Zeitler, ... Cancer letters 164 (2), 197-205, 2001 | 26 | 2001 |
| Biologic characteristics of patients with hypocellular myelodysplastic syndromes R Goyal, H Qawi, I Ali, S Dar, S Mundle, V Shetty, Y Mativi, K Allampallam, ... Leukemia research 23 (4), 357-364, 1999 | 26 | 1999 |
| Encouraging improvement in cytopenias of patients with myelodysplastic syndromes (MDS) with thalidomide. Abstract# 111 A Raza, L Lisak, C Andrews, L Little, F Zorat, V Shetty, S Alvi, S Mundle, ... Amer. Soc. of Clinical Oncology, 2000 | 21 | 2000 |
| Cytokines and MDS K Allampallam, VT Shetty, A Raza Cancer Treat Res 108, 93-100, 2001 | 17 | 2001 |
| Biologic and clinical response to recombinant human soluble tumor necrosis factor receptor (enbrel) in patients with myelodysplastic syndromes (MDS). A Raza, K Allampallam, V Shetty, S Mundle, R Borok, L Lisak, C Andrews, ... Blood 94 (10), 171B-171B, 1999 | 16 | 1999 |
| Thalidomide significantly augments proliferation and cytokine secretion in bone marrow cultures established from myelodysplastic syndrome (MDS) patients. S Alvi, S Anthwal, M Shaikh, A Shaher, V Shetty, S Mundle, P Reddy, ... Blood 98 (11), 352A-352A, 2001 | 12 | 2001 |
| Effects of anti-cytokine agents on apoptosis, proliferation, monocyte/macrophage number, microvessel density and cytokines following two successive clinical trials in 57 … V Shetty, K Allampallam, S Hussaini, W Townsend, D Dutt, S Mundle, ... BLOOD 98 (11), 275B-275B, 2001 | 11 | 2001 |
| Cytogenetic and clonal profile of myelodysplastic syndromes (MDS) patients treated with thalidomide S Alvi, M Shaikh, S Anthwal, A Shaher, D Tamoseviciene, A Novick, ... Blood 98 (11), 352a, 2001 | 10 | 2001 |
| Thalidomide in myelodysplasia S Mundle, F Zorat, V Shetty, K Allampallam, S Alvi, L Lisak, L Little, ... Abstract 626, 1-5, 0 | 10 | |
| Biologic determinants of clinical response to thalidomide in myelodysplasia (abstract 626) S Mundle, F Zorat, V Shetty, K Allampallam, S Alvi, L Lisak, L Little, ... Blood 96 (suppl 1), 146a, 2000 | 4 | 2000 |
| The clinical and biologic significance of apoptosis, macrophages and cytokines in 145 patients with myelodysplastic syndromes (MDS). K Allampallam, V Shetty, L Broady-Robinson, S Hussaini, E Broderick, ... Blood 96 (11), 359A-359A, 2000 | 2 | 2000 |
